Published in Contact Dermatitis on September 01, 2004
Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission. Evid Based Complement Alternat Med (2011) 0.81
Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med (2009) 4.48
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med (2013) 3.81
Evidence for a cross-talk between human neutrophils and Th17 cells. Blood (2009) 2.75
Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet (2002) 2.15
N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH. Rheumatol Int (2007) 2.03
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet (2011) 1.80
Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem (2002) 1.69
Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet (2003) 1.64
Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int (2010) 1.59
Human parvovirus B19 infection and autoimmunity. Autoimmun Rev (2008) 1.38
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med (2006) 1.34
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet (2011) 1.24
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet (2012) 1.17
Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int (2005) 1.03
Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med (2005) 0.98
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet (2013) 0.94
Dermatomyositis complicated with Kaposi sarcoma: a case report. Clin Rheumatol (2006) 0.92
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment. Int Immunol (2009) 0.91
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS One (2013) 0.91
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis. Arthritis Res Ther (2012) 0.90
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis (2012) 0.89
Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report. J Med Invest (2007) 0.89
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Rheumatology (Oxford) (2011) 0.88
Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta (2006) 0.88
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res Ther (2014) 0.87
Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence? Dig Liver Dis (2011) 0.86
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis. Ann Rheum Dis (2011) 0.85
Sensori-neural deafness and hypothyroidism: autoimmunity causing 'pseudo-Pendred syndrome'. Horm Res (2006) 0.84
Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol (2005) 0.83
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis (2012) 0.83
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. Arthritis Res Ther (2012) 0.83
Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome. J Autoimmun (2005) 0.82
Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS One (2007) 0.82
The interaction between MTHFR 677 C-->T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr (2003) 0.82
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. Autoimmunity (2013) 0.82
Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther (2010) 0.81
In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells. PLoS One (2013) 0.81
DNase I behaves as a transcription factor which modulates Fas expression in human cells. Eur J Immunol (2004) 0.81
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. J Rheumatol (2007) 0.80
A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84. Immunol Res (2013) 0.80
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility. Arthritis Res Ther (2014) 0.80
The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J Rheumatol (2003) 0.80
[HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations]. Recenti Prog Med (2005) 0.79
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus. Arthritis Rheumatol (2014) 0.78
Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature. Autoimmun Rev (2011) 0.78
Prevalence of hereditary hyperferritinemia-cataract syndrome in blood donors and patients with cataract. Haematologica (2003) 0.77
Leprosy initially misdiagnosed as sarcoidosis, adult-onset still disease, or autoinflammatory disease. J Clin Rheumatol (2011) 0.77
The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions. J Rheumatol (2002) 0.77
Dextran-specific IgG response in hypersensitivity reactions to measles-mumps-rubella vaccine. J Allergy Clin Immunol (2008) 0.76
Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease. Int Immunol (2012) 0.76
The role of peptide libraries in the identification of novel autoantigen targets in autoimmune diseases. Discov Med (2010) 0.76
Reactive arthritis following BCG immunotherapy for bladder carcinoma. Clin Rheumatol (2005) 0.75
The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis. Isr Med Assoc J (2002) 0.75
Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis. Int Immunol (2010) 0.75
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor. Arthritis Res Ther (2012) 0.75
Systemic sclerosis and superficial siderosis of the central nervous system: casuality or causality? Rheumatol Int (2008) 0.75
Modulation of adaptive immune response following intravenous immunoglobulin therapy in common variable immunodeficiency. Isr Med Assoc J (2014) 0.75
Cystatin C versus creatinine in renovascular disease. Clin Chem (2002) 0.75
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis. J Rheumatol (2017) 0.75